The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
CBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
c-MYC: more than just a matter of life and death
Pelengaris, S., Khan, M., & Evan, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc904 · Cited by 1,178
Yao, T.-P., Oh, S. P., Fuchs, M., Zhou, N.-D., Ch'ng, L.-E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., & Eckner, R. (1998) · Cell · doi:10.1016/s0092-8674(00)81165-4 · Cited by 1,014
The inhibitors of apoptosis (IAPs) and their emerging role in cancer
LaCasse, E. C., Baird, S., Korneluk, R. G., & MacKenzie, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1202569 · Cited by 982
A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription
Emami, K. H., Nguyen, C., Ma, H., Kim, D. H., Jeong, K. W., Eguchi, M., Moon, R. T., Teo, J.-L., Oh, S. W., Kim, H. Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404875101 · Cited by 874
Self-citationLin, S.-Y., Xia, W., Wang, J. C., Kwong, K. Y., Spohn, B., Wen, Y., Pestell, R. G., & Hung, M.-C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060025397 · Cited by 783
Analysis of human transcriptomes
Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., et al. (1999) · Nature Genetics · doi:10.1038/70487 · Cited by 774
OMURA, S., IWAI, Y., HIRANO, A., NAKAGAWA, A., AWAYA, J., TSUCHIYA, H., TAKAHASHI, Y., & ASUMA, R. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.275 · Cited by 674
Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240390697 · Cited by 611
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600
Uren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527
β-Catenin mutations in cell lines established from human colorectal cancers
Ilyas, M., Tomlinson, I. P. M., Rowan, A., Pignatelli, M., & Bodmer, W. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10330 · Cited by 494
p300 Transcriptional Repression Is Mediated by SUMO Modification
Girdwood, D., Bumpass, D., Vaughan, O. A., Thain, A., Anderson, L. A., Snowden, A. W., Garcia-Wilson, E., Perkins, N. D., & Hay, R. T. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00141-2 · Cited by 454
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L.-E., Sieff, C. A., Livingston, D. M., & Yao, T.-P. (2000) · Genes & Development · doi:10.1101/gad.14.3.272 · Cited by 440
Conjunction dysfunction: CBP/p300 in human disease
Giles, R. H., Peters, D. J. M., & Breuning, M. H. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01438-3 · Cited by 403
Contribution of stem cells and differentiated cells to epidermal tumours
Owens, D. M., & Watt, F. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1096 · Cited by 346
Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation
Kawasaki, H., Eckner, R., Yao, T.-P., Taira, K., Chiu, R., Livingston, D. M., & Yokoyama, K. K. (1998) · Nature · doi:10.1038/30538 · Cited by 330
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
Bafico, A., Liu, G., Goldin, L., Harris, V., & Aaronson, S. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.032 · Cited by 324
Survivin and molecular pathogenesis of colorectal cancer
Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R., & Altieri, D. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13910-4 · Cited by 323
A p34cdc2 survival checkpoint in cancer
O'Connor, D. S., Wall, N. R., Porter, A. C. G., & Altieri, D. C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00084-3 · Cited by 315
Survivin study: What is the next wave?
Li, F. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10327 · Cited by 309
Speliotes, E. K., Uren, A., Vaux, D., & Horvitz, H. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00023-x · Cited by 244
Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal
Rebel, V. I., Kung, A. L., Tanner, E. A., Yang, H., Bronson, R. T., & Livingston, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232568499 · Cited by 244
Goyette, M. C., Cho, K., Fasching, C. L., Levy, D. B., Kinzler, K. W., Paraskeva, C., Vogelstein, B., & Stanbridge, E. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1387 · Cited by 243
Maeda, O., Usami, N., Kondo, M., Takahashi, M., Goto, H., Shimokata, K., Kusugami, K., & Sekido, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1207254 · Cited by 172
Transcriptional analysis of human survivin gene expression
LI, F., & ALTIERI, D. C. (1999) · Biochemical Journal · doi:10.1042/bj3440305 · Cited by 171
Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice
Yamauchi, T., Oike, Y., Kamon, J., Waki, H., Komeda, K., Tsuchida, A., Date, Y., Li, M.-X., Miki, H., Akanuma, Y., et al. (2002) · Nature Genetics · doi:10.1038/ng829 · Cited by 166
Roth, J.-F., Shikama, N., Henzen, C., Desbaillets, I., Lutz, W., Marino, S., Wittwer, J., Schorle, H., Gassmann, M., & Eckner, R. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg473 · Cited by 159
Beta-catenin signaling in prostate cancer: an early perspective.
Chesire, D. R., & Isaacs, W. B. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100537 · Cited by 129
Miyagishi, M., Fujii, R., Hatta, M., Yoshida, E., Araya, N., Nagafuchi, A., Ishihara, S., Nakajima, T., & Fukamizu, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000258200 · Cited by 127
A Cinderella Caspase Takes Center Stage
Kumar, S., & Vaux, D. L. (2002) · Science · doi:10.1126/science.1076118 · Cited by 113
Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator
Suganuma, T., Kawabata, M., Ohshima, T., & Ikeda, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192586699 · Cited by 70
Baluchamy, S., Rajabi, H. N., Thimmapaya, R., Navaraj, A., & Thimmapaya, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633700100 · Cited by 43
Cited by
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Self-citationCan we safely target the WNT pathway?
Kahn, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4233 · Cited by 1,034
Self-citationLiu, P., Wang, Y., Yang, G., Zhang, Q., Meng, L., Xin, Y., & Jiang, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105420 · Cited by 761
β-Catenin hits chromatin: regulation of Wnt target gene activation
Mosimann, C., Hausmann, G., & Basler, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2654 · Cited by 575
Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
Takahashi-Yanaga, F., & Kahn, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2943 · Cited by 499
Self-citation
Metadata
- Authors
- Ma, H., Nguyen, C., Lee, K.-S., & Kahn, M.
- Venue
- Oncogene
- Published
- 2005-03-14
- Volume
- 24
- Issue
- 22
- Pages
- 3619-3631
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2056801328
- Cited by
- 307
- References
- 41
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.